Khalifa Alrajeh

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 9

Top Topics

Cardiovascular Disease

Cancer Stem Cells

Intellectual Disability

Top Venues

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics 24 (1) (2023)
Khalifa Alrajeh, Youssef M Roman
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics (2023)
Khalifa Alrajeh, Ola AlAzzeh, Youssef M Roman
The frequency of major ABCG2 , SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing. Pharmacogenomics (2023)